EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cancer of the ovary, fallopian tube, and peritoneum: 2025 update

Malte Renz, Michael Friedlander, Jonathan S Berek

International Journal of Gynecology & Obstetrics · 2025-09 · 171 (S1) · 6-35

DOI: 10.1002/ijgo.70282 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 04.09.2025. Verfasst von Malte Renz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 285 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high‐grade serous carcinomas (HGSCs). Stage IC is now divided into three categories: IC1 (surgical spill), IC2 (capsule ruptured before surgery or tumor on ovarian or fallopian tube surface), and IC3 (malignant cells in the ascites or peritoneal washings). The updated staging includes a revision of Stage IIIC based on spread to the retroperitoneal lymph nodes alone without intraperitoneal dissemination. This category is now subdivided into IIIA1(i) (metastasis ≤10 mm in greatest dimension) and IIIA1(ii) (metastasis >10 mm in greatest dimension). Stage IIIA2 is now “microscopic extrapelvic peritoneal involvement with or without positive retroperitoneal lymph node” metastasis. This review summarizes the genetics, surgical management, chemotherapy, and targeted therapies for epithelial cancers, including the treatment of ovarian germ cell and stromal malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal NeoplasmsHumansFemaleNeoplasm Staging

Stichwörter der Autor:innen

FIGO cancer reportcancer stagingchemotherapyfallopian tubeovaryperitoneum

Autor:innen und Institutionen

  • Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Royal Hospital for Women, Sydney, New South Wales, Australia.
  • Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.

Zitieren

APA

Renz, M., Friedlander, M., & Berek, J. S. (2025). Cancer of the ovary, fallopian tube, and peritoneum: 2025 update. International Journal of Gynecology & Obstetrics, 171(S1), 6-35. https://doi.org/10.1002/ijgo.70282

Vancouver

Renz M, Friedlander M, Berek JS. Cancer of the ovary, fallopian tube, and peritoneum: 2025 update. International Journal of Gynecology & Obstetrics. 2025;171(S1):6-35. doi:10.1002/ijgo.70282

BibTeX
@article{Renz2025,
  author = {Renz, Malte and Friedlander, Michael and Berek, Jonathan S},
  title = {Cancer of the ovary, fallopian tube, and peritoneum: 2025 update},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  volume = {171},
  number = {S1},
  pages = {6--35},
  doi = {10.1002/ijgo.70282}
}
Kostenlos starten →